The hypophysectomized rat has been used as a model to study the effects of growth hormone deficiency on bone. Here we have investigated the influence of growth hormone administration to hypophysectomized rats for 6 weeks on accumulation of triglycerides in bone marrow and, on the differentiation of primary marrow stromal cells into adipocytes under in vitro conditions. We found that hypophysectomy significantly increased triglyceride concentration in bone marrow which was attenuated by growth hormone administration. Primary bone marrow stromal cells derived from hypophysectomized rats (HX) also had more adipocytes at confluence compared to growth hormone treated rats (GH). When stimulated with IBMX/Dex, preadipocyte colony counts increased more significantly in GH. Markers of adipocyte differentiation were higher in HX than CT or GH at confluence. However, following stimulation with IBMX/Dex, increased expression of markers was seen in GH compared to HX. Conclusion: Growth hormone administration to hypophysectomized rats attenuated triglyceride accumulation in bone marrow, and inhibited the differentiation of stromal cells into adipocytes in vitro.
Introduction
Bone marrow contains pluripotent stromal cells that are progenitors of skeletal tissue components such as bone, cartilage, the hematopoeitic-supporting stroma, and adipocytes (11, 15) . Various systemic and autocrine/paracrine factors and hormones influence the differentiation of these stromal cells into a specific cell lineage. There is an inverse relationship between the differentiation of adipocytic and osteogenic cells. For example, in all instances in which trabecular bone volume is decreased, such as in osteoporosis, the volume of marrow adipose tissue increases (17) (18) (19) . Further evidence for this inverse relationship is supported by the fact that potent agonists of osteoblast differentiation, such as the bone morphogenic proteins, inhibit adipocyte differentiation (9). Additionally, thiazolidinediones, which are adipogenic through stimulation of peroxisome proliferator-activated receptor-γ (PPARγ), inhibit osteoblast differentiation (10) . In their studies Bennett et al (2) also demonstrated that adipocytic clones could be induced to lose their accumulated lipid, re-enter a proliferation phase and subsequently express osteogenic potential when implanted in vivo within diffusion chambers. Together, these provide strong evidence for the common origin of adipocytes and osteoblasts as well as their reciprocal relationship.
Growth hormone deficiency in humans either isolated or as part of panhypopituitarism, is associated with increased adiposity and decreased bone mineral density. Treatment with growth hormone decreases body fat content by decreasing lipogenesis and increasing lipolysis (21) , while at the same time improving bone density. The hypophysectomized rat has been used as a model to study the effects of multiple pituitary hormone deficiency. In these animals as in humans, pituitary hormone deficiency induces poor weight gain but increased adipose tissue deposition while at the same time decreasing cancellous and cortical bone volume (4, 29) .
However when hypohysectomized rats were treated with growth hormone weight and bone mass increased significantly to almost control levels (5) .
The differentiation of stromal cells into adipocytes involves various stages, with preadipocytes as the immediate precursors of the mature adipocyte. The preadipocyte is a fibroblast-like cell that expresses a number of unique genes and transcription factors. Prior to differentiation into adipocytes, preadipocytes undergo growth arrest and withdrawal from the cell cycle followed by clonal expansion. Morphological changes then take place including acquisition of a spherical shape and accumulation of triglycerides. This process is associated with the appearance and expression of a number of transcription factors as well as downregulation of some genes. PPARγ is one of the earliest transcription factors to appear in the committed adipocyte, and is important in the control and synthesis of other genes, transcription factors, enzymes, transport proteins and hormones required for the metabolic activities of the mature adipocyte (15) . Lipoprotein lipase (LPL) is an enzyme that appears in the early adipocyte and is responsible for the accumulation of triglycerides in the fat cells.
Other genes controlled by these early transcription factors include adipsin and leptin, intermediate and late markers of adipocyte differentiation respectively (26) .
In recent studies it was observed that the in vitro differentiation of primary marrow stromal cells derived from hypophysectomized rats into osteoblasts is enhanced compared to control (30) . Here we have examined the effects of in vivo administration of GH to hypophysectomized rats on the accumulation of triglycerides in femur as well as in vitro induction of adipogenesis in the bone marrow stroma. The rationale for the study is that the lack of GH in the hyophysectomized rat in vivo will lead to enhanced differentiation of stromal cells into adipocytes in vivo with fewer stromal cells available for in vitro adipogenic induction.
It is expected that treatment of hypophysectomized rats with growth hormone will inhibit the commitment of bone marrow stromal cells into adipogenesis in vivo, thereby making more uncommitted stromal cells available for induction of adipogenesis under in vitro conditions.
Materials and Methods

Animal Care
Age-matched intact control and HX female 8-weeks old Sprague-Dawley rats were purchased from Hilltop (CA), where the hypophysectomies were performed. Upon arrival 4 days postoperatively the animals were divided into 3 groups of 6 each for the study design: agematched intact control (CT), hypophysectomized control (HX), and hypophysectomized + growth hormone (GH). All animals were allowed access to standard pelleted rat chow (Rodent Laboratory Chow 5001, Ralston Purina, St. Louis, MO). In addition all hypohysectomized rats were given 3% sucrose water ad lib. Animals were allowed to acclimatize for 3 days after which daily subcutaneous injections were started. The GH group received 1 mg/kg/day of recombinant human growth hormone (Genentech, San Francisco, CA) subcutaneously. Both HX and GH animals received daily subcutaneous injections of 100 ug/kg hydrocortisone (Solu-Cortef, Pharmacia, Kalamazoo, MI) in order to maintain oxygen consumption. Injections were continued for 6 weeks. Weights were recorded initially and weekly thereafter. At the end of six weeks rats were euthanized by CO 2 inhalation. Both femurs and tibias were removed under aseptic conditions and processed for cell culture. 
Cell Culture
Bone marrow stromal cells were extracted from each femur using 10 ml of basal medium made up of α-MEM (without phenol red) supplemented with10% FBS, antibiotic-antimycotic, 50ug/ml ascorbic acid and 2 mM L-glutamine, as previously described (30) . The marrow extract was sequentially passed through 18 gauge and 22 gauge needles for thorough cell suspension.
Cells were pelleted by centrifugation at 1500 rpm for 5 min. The supernatant from each femur was saved for determination of triglyceride concentration. Cell pellets were re-suspended in 3 ml basal medium. Aliquots (3 ul) in quadruplicate were smeared on glass slides for preadipocyte counts. Bone marrow cells from the two femurs of each animal then were pooled into a single suspension and aliquots taken for cell counts, after a 1:10 dilution of the cell suspension was made with 0.3 % acetic acid. Cells were then plated in 12-or 24-well dishes at a seeding density of 3.0 x 10 6 and 1.5 x 10 6 per well respectively. After 24 hrs of culture, non-adherent cells were removed and fresh medium added. Thereafter medium was changed every other day.
Adipocyte Induction
Marrow stromal cells plated at 1.5 x 10 6 per well were cultured in basal medium until confluent, 
Neutral Lipid Accumulation
Lipid accumulation in adipocytes was determined by oil red-O staining in smears from the cell suspension, confluent cells and in cells treated with or without Dex/IBMX after confluence, as previously described (8) . In order to determine preadipocyte count in bone marrow extracts, 3 ul aliquots of cell suspension were smeared on slides, dried in air and stained with oil red-O. Four adjacent 1 mm squares from 4 smears were counted using phase contrast microscope. For cells grown in culture, medium was removed from 24-well culture dishes and cells washed once with PBS. The dishes as well as slides were fixed in 8% paraformaldehyde for 20 min. They were washed with PBS, dried and stained with oil red-O. Mature adipocytes and preadipocyte colonies were manually counted using a phase contrast microscope. Thereafter oil red-O from the wells was extracted with 100 % iso-propyl alcohol for triglyceride determination. Mature adipocytes tend to have a large lipid vacuole that occupies most of the cytoplasm, pushing the nucleus to the periphery. Preadipocytes, on the other hand, are fibroblast-like in nature and tend to have intracytoplasmic inclusion vacuoles that are much smaller. In this paper we have classified a "preadipocyte colony" as a group of at least 3 preadipocytes lying close together.
Triglyceride Quantitation
Triglyceride content of supernatant samples from rat femurs was determined as previously described (24) Hybridization was carried out overnight at 45°C, followed by 1 or 2 washes at room temperature with 2X SSC/0.1% SDS for 15 min each. The membranes were exposed to Fuji NIF film for variable periods of time with intensifying screens at -80°C.
RT/PCR and Southern Blot Analysis
RNA (1 ug) was initially treated with DNase I, reverse transcribed and subjected to amplification by polymerase chain reaction as previously reported (32) . The sequence for the GAPDH primers have been previously reported (32) .
Semi-Quantitative Analysis
Blots were scanned with an HP Desk II scanner for band intensities which were subsequently analyzed with the SigmaGel computer program. GAPDH expression was used to normalize the data for the PCR while intensity of the 28S band was used to normalize the northern blot analysis data.
Statistical Analysis
The 2-tailed Student's t-test was used to compare differences in response between the groups to both in vivo and in vitro conditions. A p value of <0.05 was considered as significant.
Results
A/ In Vivo Adipogenesis
The weights of the rats in the various groups are shown in Table1 In order to study the effect of in vivo GH treatment on bone marrow adipogenesis, the triglyceride content of bone marrow extracted from the femurs and the number of preadipocytes were determined as well (Fig. 1) . The number of preadipocytes in the smear expressed as a percent of oil red-O positive cells was significantly lower and the triglyceride content of femur was significantly higher in the HX group than that of the CT group. In vivo growth hormone treatment of HX resulted in significant increase in preadipocytes but a significant reduction of triglyceride content of femur.
B/ In Vitro Adipogenesis
Since hypophysectomy is known to cause increased adipogenesis in vivo, the influence of in vivo treatment of hypophysectomized rats with growth hormone on the ability of primary marrow stromal cells to differentiate into adipocytes was studied under cell culture conditions. The number of adipocytes and preadipocytes were counted and expression of markers of adipocyte differentiation (PPARγ2, LPL, adipsin and leptin) measured at confluence, day 4 and day 10 post-confluence under basal conditions and after stimulation with 1-iso-3-methylxanthine (IBMX) 450 uM and Dexamethasone (Dex) 1 uM for 3 days. In pilot studies involving three different concentration levels of IBMX/Dex, the greatest response in terms of adipocyte marker induction was seen with 1 uM Dex and 450uM IBMX (data not shown). Figure 2A shows expression of the mature adipocyte phenotype when primary marrow stromal cells were followed in culture until confluent and up to 10 days post confluence. At confluence the adipocyte count was significantly higher in the HX group but lower in the GH group when compared to CT. The number of adipocytes decreased in all groups by day 4 post-confluence and persisted to day 10. Treatment of confluent cells with IBMX/Dex did not affect the mature adipocyte numbers (Fig. 2B) .
C/ Mature Adipocytes
D/ Preadipocyte Colonies
The number of preadipocyte colonies was highest in GH group at confluence and lowest in CT.
In non-stimulated cells there was no significant change in the colony counts at 4 days post confluence when compared to confluence levels but by 10 days post confluence there was a slight increase in CT and HX (Fig. 2C) . Stimulation of confluent cells with IBMX/Dex resulted in significant increase in preadipocyte colony counts in all 3 groups at day 4. The GH group had a significantly higher preadipocyte colony count than HX at day 4 that persisted to day 10, although at a lower level (Fig. 2D ).
E/ Triglyceride Extraction
Oil red-o was extracted from culture wells in order to determine the accumulation of triglycerides under in vitro conditions (Fig. 3) . There was significantly more triglycerides in GH There was an increase of 41% in OD of the GH group which was significantly different from that of both CT and HX (p value <0.01). By day 10 post confluence the increase in GH persisted but lower at 21%, which was still significantly different from HX (p value <0.001).
F/ Markers of Adipocyte Differentiation
The expression of mRNA for all four markers was detected in the three groups when primary rat marrow stromal cells were grown to confluence and then followed for up to 10 days postconfluence (Fig. 4) .
After confluence, cells were followed in culture for up to 10 days with or without stimulation with IBMX/Dex and the expression of markers of adipocyte differentiation determined. Under basal conditions, the expression of leptin mRNA decreased in HX and CT by day 4 post-confluence with almost undetectable levels in HX by day 10-post confluence (Fig.   5A ). In the GH group expression of leptin mRNA increased by day 4 post-confluence and then Stimulation with IBMX/Dex caused a decrease in expression of adipsin in HX at day 4, but an increased expression was observed in GH when compared to non-stimulated cells (Fig.   5B ). There was a significant increase in adipsin expression in all 3 groups at 10 days following stimulation with IBMX/Dex.
The expression of LPL mRNA was increased in stimulated cells from CT and GH by day 4 but decreased similarly treated cells from HX. By day 10, however, there was no difference in the expression of LPL mRNA between cells from all 3 groups whether stimulated with or without IBMX/Dex (Fig. 5C ).
At day 4 post-confluence the expression of mRNA for PPARγ2 expression was similar in stimulated and non-stimulated CT and GH groups (Fig. 5D ). However, there was a decreased expression of mRNA in the stimulated HX group. By day 10, whereas significant increases were observed in the CT and GH groups following IBMX/Dex stimulation, a significant decrease occurred in HX leading to almost undetectable levels.
Discussion
Hypophysectomy resulted in increased bone marrow adipogenesis and fat accumulation compared to the control rats, as demonstrated by the increased triglyceride content of bone marrow. Treatment of hypophysectomized rats with GH reversed these changes. The increased adipogenesis in HX rats continued in vitro when primary bone marrow stromal cells were 14 allowed to grow to confluence under basal conditions. This was reflected not only in the higher number of adipocytes in HX rats, but also in increased expression of markers of adipocyte maturation: PPARγ2, adipsin and leptin. The data suggests that growth hormone inhibits differentiation of marrow stromal cells into adipocytes and that its absence in HX rats allowed the pluripotent bone marrow stromal cells to differentiate along the adipocyte pathway leading to increased adipogenesis. Furthermore, the effects due to lack of growth hormone in HX rats in vivo persisted in vitro since there was significantly less adipocytes in GH than HX or CT at confluence. This finding is supported by that of Deslex et al (6) as well as Hansen et al (12) . In studies using primary preadipocytes directly obtained from rats, it was reported that growth hormone stimulated proliferation and had a potent inhibitory effect of on differentiation of preadipocytes into mature adipocytes. However, in other studies in which preadipocyte cell lines such as 3T3-F422A, 3T3-L1, and Ob1771were used, growth hormone was shown to inhibit proliferation of preadipocytes and promote their differentiation into mature adipocytes (28) . Thus it appears that the role of growth hormone in adipocyte differentiation varies depending on the type of cells used, being adipogenic in preadipocyte cell lines and anti-adipogenic in both primary marrow stromal cells and primary preadipocytes .
Since both osteoblasts and adipocytes are derived from the same mesenchymal progenitor cells, stimulation of adipogenesis and accumulation of fat in bone marrow would be expected to lead to decreased bone formation and osteopenia/osteoporosis in the long term. Previous studies have demonstrated that hypophysectomy leads to a decrease in bone mineral density in rats, and that treatment with growth hormone partially reverses this syndrome (30) . Also in humans, growth hormone deficiency is known to cause osteopenia or osteoporosis which is significantly improved following initiation of growth hormone therapy (14) . Consistent with these findings, administration of growth hormone to HX rats in our study reduced the fat content of the femur towards levels found in the control rats. A combination of factors could account for the reduction of bone marrow fat content of the femur under the influence of growth hormone. In part, this could be due to the inhibition of stromal cell differentiation into adipocytes while at the same time stimulating differentiation along the osteoblast pathway (30) . The direct metabolic effects of growth hormone on adipocytes also could play a role in the decrease in marrow fat content of femur. In human adipose tissue growth hormone suppresses lipogenesis by inhibiting lipoprotein lipase (21, 25) . In addition, Dietz et al (7) reported the activation of hormone sensitive lipase by growth hormone in 3T3-F422A preadipocytes leading to increased lipolysis. Together, these studies suggest that growth hormone can act via multiple mechanisms to reduce the accumulation of fat in the bone marrow of femur.
In culture, adipocyte counts progressively decreased in all three groups of rats after cells became confluent, with a more rapid decline noted in HX. Several reasons could account for this. First, mature adipocytes are less adherent and more buoyant than preadipocytes owing to their content of low density lipid (8) . Thus it is possible that some are mechanically removed during media change. Secondly, mature adipocytes can undergo apoptosis when cultured in vitro due to various factors such as serum deprivation and heat injury (23) . Other agents including tumor necrosis factor-α and all-trans retinoic acid also induce apoptosis of human and rat adipocytes respectively (13, 22) . In contrast, other studies have reported that although the 3T3-L1 preadipocytes undergo apoptosis when subjected to growth factor deprivation they become resistant after differentiation to adipocytes. However, Zhang et. al. (31) reported that apoptosis was observed in 10-15% of mature human adipocytes cultured in normal, serum-containing media with no apoptosis-inducing agents. Our data suggests that apoptosis of mature adipocytes might have occurred after growing to confluence in normal media, and that the lack of growth hormone in vivo may have accelerated the process in the HX group. We have not, however, been able to conclusively establish this fact and further studies are needed.
Dexamethasone used in combination with IBMX is a standard protocol for in vitro induction of differentiation in preadipocyte cell lines as well as primary bone marrow stromal cells into mature adipocytes (15, 26) . Confluent cells are treated for 3 days with Dex/IBMX and withdrawn. We did not observe any increase in adipocyte counts when confluent primary marrow stromal cells from rats were stimulated with Dex/IBMX. In fact, when followed for up However, Smas et al (26) showed that dexamethasone induces downregulation of pref-1 mRNA during the induction phase which is necessary before the appearance of the adipogenic transcription factors. Although no increase in adipocyte counts was noted, the expression of mRNA for PPARγ2, adipsin and leptin was increased in GH 2 days after removal of Dex/IBMX and persisted. Thus it is expected that there will be a lag period between the decrease in adipocyte number in culture and the appearance of new, differentiated, mature adipocytes. This will account for our observation that there was no increase in mature adipocyte numbers in the Both adipocytes and preadipocytes can undergo dedifferentiation under appropriate stimulation conditions (2) . In humans and rats, osteopenia induced by growth hormone deficiency is improved by growth hormone administration (5, 14) . This could occur by one of two mechanisms: stimulation of uncommitted stromal cells to differentiate into osteoblasts or dedifferentiation of preadipocytes and some adipocytes into osteoblasts. Adipocytes that have not reached terminal differentiation are capable of dedifferentiation (15) . The data presented here suggests that there is a pool of committed stromal cells that were still undergoing differentiation together with preadipocytes. This would account for the significantly higher number of adipocytes at confluence in the HX group compared to either the GH or control groups. Thus it would appear that there is a population of committed marrow cells and preadipocytes under conditions of growth hormone deficiency that could be induced to dedifferentiate into osteogenic lineage under the influence of growth hormone administration.
In this study we have used hypophysectomized rats as a model of growth hormone deficiency to investigate adipogenesis in the absence or presence of growth hormone. There are two possible confounding factors that could have accounted for our findings. First, hypophysectomy leads to deficiency of other pituitary hormones in addition to growth hormone, such as adrenocorticotrophic hormone (ACTH) and prolactin, which could have contributed to the observed alterations in bone marrow adipogenesis. However, this is unlikely, as the lack of ACTH and prolactin would have affected both groups of hypophysectomized rats equally.
Additionally, the only experimental variable between the two groups of hypophysectomized rats was the administration of growth hormone to one and not the other. Secondly, hydrocortisone is an adipogenic agent and its administration could theoretically have affected our data. The fact that both groups of hypophysectomized rats received the same dose of hydrocortisone in replacement for the lack of cortisol due to the absence of ACTH means that there will be no preferential effects in one group compared to the other.
In conclusion, growth hormone administration to hypophysectomized rats resulted in inhibition of bone marrow adipogenesis in vivo, which persisted when bone marrow stromal cells were grown to confluence in vitro. However, although significantly more preadipocyte colonies were formed in the GH group when postconfluent cells were stimulated with Dex/IBMX, the in vivo signals received from growth hormone administration seems to block their progression to fully matured adipocytes. Further studies will be needed to characterize the nature and mechanism of this differentiation arrest. During the review of this manuscript, a study RNA was extracted from confluent primary bone marrow stromal cells and subjected to northern blot analysis or RT-PCR to determine the expression of various adipocyte markers. n=3
replicates. 
